166 related articles for article (PubMed ID: 523342)
1. Alteration of brain noradrenaline, dopamine and 5-hydroxytryptamine levels during vanadium poisoning.
Witkowska D; Brzeziński J
Pol J Pharmacol Pharm; 1979; 31(4):393-8. PubMed ID: 523342
[TBL] [Abstract][Full Text] [Related]
2. Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the rat.
Benfield DP; Luscombe DK
Arzneimittelforschung; 1983; 33(6):847-50. PubMed ID: 6684438
[TBL] [Abstract][Full Text] [Related]
3. The effect of alpha, alpha1-dipyridyl on noradrenaline, dopamine and 5-hydroxytryptamine levels and on dopamine-beta-hydroxylase activity in brain.
Mogilnicka E; Szmigielski A; Niewiadomska A
Pol J Pharmacol Pharm; 1975; 27(6):619-24. PubMed ID: 1715
[TBL] [Abstract][Full Text] [Related]
4. Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats.
Sheikh N; Ahmad A; Siripurapu KB; Kuchibhotla VK; Singh S; Palit G
J Ethnopharmacol; 2007 May; 111(3):671-6. PubMed ID: 17321089
[TBL] [Abstract][Full Text] [Related]
5. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
Tseng LF; Menon MK; Loh HH
J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
[TBL] [Abstract][Full Text] [Related]
6. Effects of histamine H1- and H2-receptor antagonists on dopamine, noradrenaline and serotonin systems in rat brain.
Nowak JZ
Pol J Pharmacol Pharm; 1980; 32(4):451-61. PubMed ID: 6114483
[TBL] [Abstract][Full Text] [Related]
7. Influence of supidimide on brain neurotransmitter systems of rats and mice.
Hennies HH; Günzler WA; Flohé L
Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain.
Ardis TC; Cahir M; Elliott JJ; Bell R; Reynolds GP; Cooper SJ
J Psychopharmacol; 2009 Jan; 23(1):51-5. PubMed ID: 18562433
[TBL] [Abstract][Full Text] [Related]
9. Central effects of prostaglandins F2alpha and E1.
Herman ZS; Kmieciak-Kolada K; Wolny HL; Slomińska-Zurek J; Bonczek A
Pol J Pharmacol Pharm; 1976; 28(5):411-21. PubMed ID: 1012972
[TBL] [Abstract][Full Text] [Related]
10. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
Tessel RE; Rutledge CO
J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
[TBL] [Abstract][Full Text] [Related]
11. Time-course of trimethyltin effects on the monoaminergic systems of the rat brain.
Andersson H; Luthman J; Lindqvist E; Olson L
Neurotoxicology; 1995; 16(2):201-10. PubMed ID: 7566680
[TBL] [Abstract][Full Text] [Related]
12. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
Chen NH; Reith ME
J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
[TBL] [Abstract][Full Text] [Related]
13. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex.
Yoshitake T; Yoshitake S; Fujino K; Nohta H; Yamaguchi M; Kehr J
J Neurosci Methods; 2004 Dec; 140(1-2):163-8. PubMed ID: 15589346
[TBL] [Abstract][Full Text] [Related]
14. Effect of some quinolizidine derivatives on the release of serotonin, noradrenaline, dopamine and acetylcholine from rat brain synaptosomes.
Sparatore A; Marchi M; Maura G; Raiteri M
Farmaco; 1989 Dec; 44(12):1205-16. PubMed ID: 2634407
[TBL] [Abstract][Full Text] [Related]
15. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
Kihara T; Ikeda M
J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic diazepam and medazepam treatment on the level of biogenic monoamines in different rat brain areas.
Stancheva S; Petkov VV
Acta Physiol Pharmacol Bulg; 1988; 14(3):26-31. PubMed ID: 2906206
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
Ahtee L; Attila LM; Carlson KR
J Pharmacol Exp Ther; 1990 Nov; 255(2):803-8. PubMed ID: 2243351
[TBL] [Abstract][Full Text] [Related]
18. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
Petkov VV; Grahovska T; Petkov VD; Konstantinova E
Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic exposure to cadmium, lead and mercury of brain biogenic amines in the rat.
Hrdina PD; Peters DA; Singhal RL
Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):483-93. PubMed ID: 996361
[TBL] [Abstract][Full Text] [Related]
20. [Effect of prolonged hypokinesia on the biogenic amine content of rat brain synaptosomes].
Panusheva NN
Biull Eksp Biol Med; 1983 Dec; 96(12):12-4. PubMed ID: 6686464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
